David Moss, Founder of InMuneBio

Dementia & Alzheimer's: Brain Immune Cells Therapeutics. Researchers are exploring innovative therapies for Dementia and Alzheimer's by focusing on the role of brain immune cells. The immune cells within the brain play a crucial role in maintaining neural health and function. Studies suggest that dysregulation of these immune cells may contribute to the progression of neurodegenerative diseases like Alzheimer's. Therapeutic interventions aim to modulate the activity of these immune cells to potentially slow down or mitigate cognitive decline. Strategies include harnessing the brain's immune response to clear abnormal protein aggregates linked to Alzheimer's pathology. This burgeoning field holds promise for developing targeted treatments that address the underlying immunological aspects of Dementia and Alzheimer's, opening new avenues for combating these challenging conditions

In our exploration of innovative therapeutics, we engage with David Moss, the founder of InMuneBio, a company at the forefront of groundbreaking research. Their approach zeroes in on immune cells within the brain as a potential treatment for Alzheimer's and other forms of dementia. This novel strategy represents a departure from conventional methods, introducing a fresh perspective that holds the promise of efficacy.

Treatment or Prevention on the Horizon?

The excitement surrounding InMuneBio's research is bolstered by the successful completion of a stage one clinical trial, showcasing positive results. The implications of this achievement extend beyond mere optimism, hinting at a potential paradigm shift in how we perceive and address these debilitating neurodegenerative conditions.

As we delve into the details of InMuneBio's therapeutic approach, we uncover the intricacies of targeting brain immune cells. The significance of this methodology lies not only in its innovative nature but also in the possibility of offering tangible benefits to individuals grappling with the challenges of Alzheimer's and related dementias.

Our conversation with David Moss serves as a window into the evolving landscape of dementia and Alzheimer's research. It explores the potential breakthroughs that could redefine the treatment landscape and provide hope to those affected. Join us on this journey of discovery, as we navigate the complexities of neurodegenerative diseases, shedding light on the latest advancements and their implications for the future of healthcare.

Learn more about INmunebio Here

+++++++++++++++++++++++++++++++++++++++++

Related Episodes:

Alzheimer's Skin Test for Early Diagnosis

New Alzheimer's Treatment? Impact Inflammation

++++++++++++++++++++++++++++++++++++++++

Sign Up for more Advice & Wisdom - email newsletter.

++++++++++++++++++++++++++++++++++++++++

Make Your Brain Span Match Your LifeSpan

Relevate from NeuroReserve

With Relevate nutritional supplement, you get science-backed nutrition to help protect your brain power today and for years to come. You deserve a brain span that lasts as long as your lifespan.

++++++++++++++++++++++++++++++++++++++++

Please help us keep our show going by supporting our sponsors. Thank you.

Stop 100% of Unwanted Calls with imp.

Did you know people with Alzheimer's can receive nearly 200 spam calls a week? You can put a stop to those now.

++++++++++++++++++++++++++++++++++++++++

Join Fading Memories On Social Media!

If you've enjoyed this episode, please share this podcast with other caregivers! You'll find us on social media at the following links.

Instagram

Twitter

LinkedIn 

Facebook

Contact Jen at [email protected]

or Visit us at www.FadingMemoriesPodcast.com